SynVaccine
1 known investors
SynVaccine develops technology for the computer-aided design and construction of viral genomes, applying synthetic and computational biology to create viral-based products such as vaccines and viral-based therapeutics. The company targets applications in human pharma and animal health.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Founders & leadership
TT
Tamir TullerCo-founder & CSO
OB
Oren BoginInterim CEO
DZ
David ZigdonExecutive Chairman